Filtros de búsqueda

Lista de obras de

28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures

artículo científico publicado en 2008

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

artículo científico publicado en 2009

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

artículo científico publicado en 2010

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

artículo científico publicado en 1998

Quality assessment of genetic markers used for therapy stratification.

artículo científico publicado en 2003

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project

artículo científico publicado en 2012

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

artículo científico publicado en 2011

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report

artículo científico publicado en 2008

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

artículo científico publicado en 2008